3 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
Follow Candidiasis, Invasive: new trials by email Literature Review of Candidiasis, Invasive trials Research Report on Candidiasis, Invasive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064) Caspofungin, Amphotericin B Deoxycholate - Candidiasis, Invasive | Phase 2 | Terminated | Merck Sharp & Dohme LLC | 51 | 2014-01-15 | 2019-11-25 |
| Pilot Feasibility Study With Patients Who Are at High Risk For Developing Invasive Candidiasis in a Critical Care Setting (MK-0991-067) Caspofungin acetate, Placebo - Invasive Candidiasis | Phase 2 | Terminated | Merck Sharp & Dohme LLC | 15 | 2010-12-01 | 2017-03-24 |
| Anidulafungin in Patients With Hematologic Malignancies Anidulafungin - Hematologic Malignancies | Phase 2 | Terminated | Elisabethinen Hospital | 10 | 2009-10-01 | 2012-03-02 |
Candidiasis (1) · Hematologic Neoplasms (1) · Invasive Fungal Infections (1) · Mycoses (1)
Bacterial Infections and Mycoses (3) · Infections (3) · Candidiasis (2) · Invasive Fungal Infections (2) · Mycoses (2) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Neoplasms (1) · Neoplasms by Site (1)
Caspofungin (2) · Anidulafungin (1) · Saline Solution (1) · amphotericin B, deoxycholate drug combination (1)
Merck Sharp & Dohme LLC (2) · Elisabethinen Hospital (1)
Austria (1)
2009 (1)